Law360, New York (November 20, 2009, 5:43 PM ET) -- A Pennsylvania jury has ruled that two Pfizer Inc. units are on the hook for at least $6.3 million in compensatory damages to an Illinois woman who developed breast cancer after she began taking popular menopause drugs Prempro and Provera.
On Friday, Bloomberg News reported that the jury in the Philadelphia County Court of Common Pleas had issued the verdict after finding that the combination of Wyeth’s Prempro and Pharmacia & Upjohn’s Provera substantially contributed to 66-year-old plaintiff Donna Kendall’s breast cancer.
The jury's award marks...
Pfizer Hit With $6.3M Prempro Verdict In Pa.
To view the full article, take a free trial now.
